Aslera™ improves bone mineral density in lupus patients

Philadelphia, Pa. - Oct. 31, 2000 - Aslera™ (GL701 or prasterone) improves bone mineral density (BMD) and prevents BMD loss in female patients with systemic lupus erythematosus (SLE or lupus) who receive treatment with prednisone, according to data from a Phase III placebo-controlled, double-blind multicenter study presented at the 64th Annual Scientific Meeting of the American College of Rheumatology in Philadelphia. Genelabs Technologies, Inc. (Nasdaq:GNLB) is developing GL701 for SLE and, if approved, it will be marketed under the name Aslera™.

Losses in BMD increase a person's risk of developing osteoporosis, making them susceptible to fractures of the hip, spine, and wrist. Female lupus patients are at risk of osteoporosis not only because they are frequently treated with bone-damaging corticosteroids, such as prednisone, to counter the abnormal immune response and inflammation that characterize lupus, but also because hormonal and other changes associated with the disease cause them to lose BMD at a higher rate.

"The improvement in BMD demonstrated in the GL701 group is an encouraging result in addition to the positive effects of GL701 for the treatment of lupus patients. Post-menopausal lupus patients are at particular risk for BMD loss, even with low dose steroid therapy, and currently available anti-resorptive agents may not be sufficiently protective, so we need alternatives that treat lupus and provide benefits, such as preserving BMD," says Ellen M. Ginzler, M.D., coauthor of the study and Professor and Chief of Rheumatology at the State University of New York Medical Center, Brooklyn.

In a placebo-controlled, double-blind multicenter Phase III study to determine whether Aslera™ would improve SLE disease activity and/or its symptoms, additional data were collected from eight sites to evaluate changes in BMD in 37 patients receiving steroid therapy. All patients were on prednisone at study entry and remained on

Contact: Beth Kaplan
Porter Novelli

Page: 1 2 3

Related biology news :

1. Aslera™ improves lupus disease activity and symptoms
2. ASU researchers demonstrate new technique that improves the power of atomic force micrscopy
3. Study shows that ultrasound accreditation improves the quality of ultrasound practice
4. Small trial shows daclizumab add-on therapy improves MS outcome
5. Combination therapy dramatically improves function after spinal cord injury in rats
6. Moderate iron deficiency affects cognitive performance - but iron supplementation improves it
7. Longer-term, moderate exercise improves immune activity
8. New approach limits damage after heart attack and improves survival, say Scripps Research scientists
9. Online calculator improves analysis of chemical data
10. Dec. 17 JAMA study shows new biologic drug reduces psoriasis symptoms, improves quality of life
11. Standard improves tests of male DNA

Post Your Comments:

(Date:4/26/2020)... ... April 23, 2020 , ... SECO , ... FII Tech Growth managed by Fondo Italiano d’Investimento SGR, today announced a partnership ... development of Respira, a new non-invasive pulmonary ventilator created in response to the ...
(Date:4/22/2020)... ... April 21, 2020 , ... ... and innovation in technology and compliance, announces a new managed service to improve ... of alliances – Box, ComplianceQuest, and USDM Life Sciences (USDM) – Unify Compliance ...
(Date:4/16/2020)... ... April 15, 2020 , ... RoosterBio Inc., a leading supplier ... announces that the Medical Technology Enterprise Consortium (MTEC) recognized a multi-institution team with ... March. The Regenerative Medicine (RegenMed) biomanufacturing collaboration had created a team initiative led ...
Breaking Biology News(10 mins):
(Date:5/21/2020)... ... May 21, 2020 , ... Threats to intellectual property, ... , Contrary to conventional wisdom that says the coronavirus pandemic will generally benefit ... emerge from the pandemic commercially weaker, dealing with delays in new product launches ...
(Date:5/21/2020)... ... ... Eaton Square is pleased to announce its growth on the East Coast of ... strategy and M&A advisory firm. , This is an important step for Eaton Square ... healthcare innovators with capital and investors. , Popper and Company, founded in 2003 by ...
(Date:5/15/2020)... , ... May 14, 2020 ... ... of human mesenchymal stem/stromal cell (hMSC) working cell banks and hMSC bioprocess ... enable streamlined and multi-format collection of hMSC-derived extracellular vesicles (EVs). RoosterCollect™-EV-CC is ...
(Date:5/15/2020)... ... 2020 , ... This new service offers clients a way to speak with ... as the need arises. Lachman’s OnCall SMEs have extensive knowledge of a wide range ... Lachman OnCall™ SMEs are available normal business hours Monday through Friday from 9:00 am ...
Breaking Biology Technology:
Cached News: